Persistent foetal vasculature: Developmental mechanisms, contemporary management and evolving therapeutics - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Persistent Fetal Vasculature: Mechanisms of Development, Current Treatment Approaches, and Advancements in Therapy

  • By

  • Robert H. Henderson

  • October 6, 2026

Share

Clinical Scorecard: Persistent Fetal Vasculature: Mechanisms of Development, Current Treatment Approaches, and Advancements in Therapy

At a Glance

CategoryDetail
ConditionPersistent fetal vasculature (PFV), a congenital ocular vascular-development disorder with anterior, posterior, or combined manifestations.
Key MechanismsPFV reflects impaired coordination among angiogenic drive, apoptotic regression, and ocular growth. The source describes HIF-VEGF signalling, macrophage-derived WNT7b, Norrin/FZD4/LRP5/6 β-catenin signalling, and ATOH7-associated PFV.
Target PopulationInfants and children with congenital ocular findings such as cataract, microphthalmia, or a dense retrolental membrane.
Care SettingThe source describes clinical classification as anterior, posterior, or combined and management decisions based on whether surgery may benefit the eye or accelerate loss of structure and comfort.

Key Highlights

  • PFV is an important cause of infantile leucocoria and can mimic retinoblastoma.
  • Among congenital cataract surgical series, PFV findings occur in approximately 20–45% of unilateral cases and 5–10% of bilateral cases.
  • Bilateral PFV frequently signals a systemic or genetic syndrome, including Norrie disease and familial exudative vitreoretinopathy.
  • Ultrasound with colour Doppler, wide-field fluorescein angiography, OCT, and OCT-angiography support subtype assessment and evaluation of ocular structure.
  • Management requires distinguishing eyes that may benefit from surgery from those in which intervention could accelerate loss of structure and comfort.

Guideline-Based Recommendations

Diagnosis

  • Classify PFV as anterior, posterior, or combined to guide clinical decisions.

Management

  • Distinguish eyes that may benefit from surgery from those in which intervention would only accelerate loss of structure and comfort.

Monitoring & Follow-up

    Risks

    • PFV is an important cause of infantile leucocoria and can mimic retinoblastoma.
    • Bilateral PFV frequently signals a systemic or genetic syndrome, including Norrie disease and familial exudative vitreoretinopathy.
    • In some eyes, intervention would only accelerate loss of structure and comfort.

    Patient & Prescribing Data

    The article describes congenital PFV, including findings such as cataract, microphthalmia, and a dense retrolental membrane.

    The supplied source passage provides no medication prescribing data and does not describe specific surgical approaches.

    Clinical Best Practices

    • Consider PFV in the assessment of infantile leucocoria and distinguish it carefully from retinoblastoma.
    • Assess for bilateral disease and possible systemic or genetic associations.
    • Use the anterior, posterior, or combined classification when considering clinical decisions.
    • Distinguish eyes that may benefit from surgery from those in which intervention would only accelerate loss of structure and comfort.

    Related Resources & Content

    Original Source(s)

    Related Content